White Paper:
The State of Immuno-Oncology

The human immune system has evolved to protect the host from minor pathogens to more serious diseases. However, when considering the complexities of cancer, the innate immune system can oftentimes fall short. Therefore, it is necessary to artificially alter the immune system to ensure it is primed to take on the task of killing cancer cells. While many advancements have  occurred in the field of immuno-oncology in the last several decades, there are many new improvements that are currently being investigated. 

This white paper will cover:

  • Innate and adaptive immunity
  • Cancer Targeting Immunotherapies
  • Adoptive T-Cell Transfer